University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
The James Cancer Hospital and Solove Research Institute, Columbus

VärbamineFaas 1/2

Vanused 16–75 · Kõik sood · Uuendatud 10. sept 2026 · NCT03104491

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Cincinnati Children's Hospital Medical Center, Cincinnati

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies and Childrens Hospital, Cleveland
ja veel 3

VärbamineFaas 1/2

Kuni 22 aastane · Kõik sood · Uuendatud 25. aug 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Cincinnati Children's Hospital Medical Center, Cincinnati

VärbamineFaas 2

Vanused 7–25 · Kõik sood · Uuendatud 19. aug 2026 · NCT05082519

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Children's Hospital Medical Center, Cincinnati

VärbamineVaatlusuuring

1 Day – 17 Years · Kõik sood · Uuendatud 14. aug 2026 · NCT06274788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Childrens Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital, Cincinnati
University Hospitals Case Medical Center, Cleveland
ja veel 3

VärbamineVaatlusuuring

Kõik vanused · Kõik sood · Uuendatud 6. juuli 2026 · NCT01351545

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Cincinnati Children's Hospital Medical Center, Cincinnati

VärbamineFaas 1/2

Kuni 21 aastane · Kõik sood · Uuendatud 3. juuni 2026 · NCT04195347

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Nationwide Children's Hospital, Columbus
Ohio State University Comprehensive Cancer Center, Columbus

VärbamineFaas 1

Vanused 2 ja vanemad · Kõik sood · Uuendatud 29. mai 2026 · NCT05418088

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati

VärbamineVaatlusuuring

Kõik vanused · Kõik sood · Uuendatud 18. mai 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Cincinnati Children's Hospital Medical Center, Cincinnati
University of Cincinnati, Cincinnati
The Ohio State University, Columbus

VärbamineFaas 1

Vanused 13 ja vanemad · Kõik sood · Uuendatud 5. mai 2026 · NCT04771572

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Ohio State University Medical Center, Columbus

VärbamineFaas 1

Vanused 18–65 · Kõik sood · Uuendatud 25. märts 2026 · NCT03533816

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

The Ohio State University Comprehensive Cancer Center, Columbus

VärbamineFaas 1/2

Vanused 12 ja vanemad · Kõik sood · Uuendatud 24. märts 2026 · NCT04988555

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Cleveland Clinic Foundation, Cleveland

VärbamineFaas 2

Vanused 18–54 · Kõik sood · Uuendatud 17. märts 2026 · NCT06918431

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Cleveland Clinic, Cleveland

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 5. nov 2025 · NCT04260022

HPC Offered for PRESERVE Expansion

The Ohio State University Medical Center, Columbus

VärbamineVaatlusuuring

Vanused 12–80 · Kõik sood · Uuendatud 28. aug 2025 · NCT07145411

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies, Cleveland
Nationwide Children's Hospital, Columbus

VärbamineFaas 1

Vanused 1–21 · Kõik sood · Uuendatud 6. dets 2024 · NCT05476770

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.